BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2 AND Treatment
9 results:

  • 1. BRAF
    Traversi F; Stooss A; Dettmer MS; Charles RP
    Thyroid; 2021 May; 31(5):787-799. PubMed ID: 33012268
    [No Abstract]    [Full Text] [Related]  

  • 2. Crosstalk between MEIS1 and markers of different cell signaling pathways in esophageal squamous cell carcinoma.
    Mahmoudian RA; Forghanifard MM
    Mol Biol Rep; 2020 May; 47(5):3439-3448. PubMed ID: 32372171
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.
    Moon JH; Rho YS; Lee SH; Koo BS; Lee HJ; Do SI; Cho JH; Eun YG; Park MW; Shin HA; Lim YC
    Oral Oncol; 2019 Sep; 96():34-41. PubMed ID: 31422211
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predicting the Correlation of EZH2 and cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.
    Karami Madani G; Rad A; Molavi M; Ardalan Khales S; Abbaszadegan MR; Forghanifard MM
    J Gastrointest Cancer; 2018 Dec; 49(4):437-441. PubMed ID: 28681114
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
    Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
    BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
    Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
    Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Activation of the NOTCH pathway in head and neck cancer.
    Sun W; Gaykalova DA; Ochs MF; Mambo E; Arnaoutakis D; Liu Y; Loyo M; Agrawal N; Howard J; Li R; Ahn S; Fertig E; Sidransky D; Houghton J; Buddavarapu K; Sanford T; Choudhary A; Darden W; Adai A; Latham G; Bishop J; Sharma R; Westra WH; Hennessey P; Chung CH; Califano JA
    Cancer Res; 2014 Feb; 74(4):1091-104. PubMed ID: 24351288
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
    Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
    J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Upregulation of Notch pathway molecules in oral squamous cell carcinoma.
    Hijioka H; Setoguchi T; Miyawaki A; Gao H; Ishida T; Komiya S; Nakamura N
    Int J Oncol; 2010 Apr; 36(4):817-22. PubMed ID: 20198324
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.